Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

like B-cell chronic leukemia and T-cell leukemia, and these deeper understandings open the door to innovative approaches that can make a difference for blood cancer patients in the future.

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

What Do Your Blood Cells Do?Leukemia develops in the blood cells produced by your bone marrow. These include: Red blood cells (RBCs), which deliver oxygen throughout the bodyWhite blood cells (WBCs), ...

Dr. Samah Nassereddine is an Assistant Professor of Medicine in the Division of Hematology & Oncology at The George ...

These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...

Three patients also had a complete remission but without higher white blood cell counts, known as a complete remission ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

Of these, chronic myeloid leukemia (CML) is a subtype that primarily affects the bone marrow, which produces blood cells. The Duke-NUS scientists, in collaboration with their partners, including ...

At the age of 30, Nicholas Filtz was diagnosed with a rare form of cancer, and on this Veterans Day, he is sharing his cancer ...